Overview
“Transforming Cardiac Amyloidosis Care: Diagnosis, Disparities, and Multidisciplinary Solutions”
Sunday March 1, 2026
Marriott Conshohocken
5.75 VOICE/SDMS/CME/CEU Credits
Join CVI for a comprehensive, full-day program focused on advancing the diagnosis, treatment, imaging, and multidisciplinary management of cardiac amyloidosis. This CME-accredited program brings together leading experts across cardiology, hematology, neurology, orthopedics, genetics, and advanced imaging to address critical challenges in care delivery, examine health disparities, and explore innovative diagnostic and therapeutic approaches. Through keynote presentations, expert-led sessions, and interactive panel discussions, participants will gain practical insights into improving patient outcomes across the full spectrum of cardiac amyloidosis care.
Attendees can earn up to:
5.75 CME/CEU/SDMS/VOICE Credits
Details
Sunday March 1, 2026
Marriott Conshohocken West
111 Crawford Avenue
Conshohocken, PA 19428
Earn 5.57 VOICE/SDMS/CME/CEU CREDITS
Intended Audience
We invite all healthcare professionals interested in cardiac amyloidosis to participate in this program. This includes but is not limited to cardiologists, primary care physicians, hematologists, neurologists, orthopedists, genetic counselors, advanced practice providers, nurses, sonographers, nuclear technologists, physician assistants, medical assistants, fellows, and residents.
*Expert Sessions: Cardiology, Hematology, Neurology, Orthopedics, Genetics, Advanced Imaging
*Explore early detection strategies, AI applications, and innovative diagnostic approaches
*Panel Discussion: Enhancing Multidisciplinary Collaboration
Course Directors
